共 50 条
- [31] First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy SubjectsJOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (12) : 1669 - 1677Zhou, JinLimsakun, TharinYin, OpheliaWarren, VanceZamora, CynthiaAtiee, GeorgeKochan, JaremaPav, JosephKobayashi, FumiakiVashi, VijayDishy, Victor
- [32] First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adultsJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 249Li, ShuyaYang, CuicuiWang, WeicongLi, JianXu, ShuhongZhao, MinXu, ChunminWang, JiaqingWang, Yongjun
- [33] First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjectsBRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (05) : 876 - 887Perera, VidyaLuettgen, Joseph M.Wang, ZhaoqingFrost, Charles E.Yones, CynthiaRusso, CesareLee, JohnZhao, YueLaCreta, Frank P.Ma, XuewenKnabb, Robert M.Seiffert, DietmarDeSouza, MaryMugnier, PierreCirincione, BrendaUeno, TakayoFrost, Robert J. A.
- [34] Safety, tolerability, and pharmacokinetics of single and multiple ascending Oral doses of DA-8010 in healthy subjects: First-in-human phase I studyPHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):Lee, Dae YoungLee, Min JungRyu, ChaelimLee, HeewonBrooks, Ashley
- [35] IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)BMJ OPEN, 2021, 11 (09):Eyerich, KilianWeisenseel, PeterPinter, AndreasSchaekel, KnutAsadullah, KhusruWegner, SvenMunoz-Elias, Ernesto J.Bartz, HolgerTaut, Friedmann J. H.Reich, Kristian
- [36] Safety, Tolerability, and Pharmacokinetics of a Novel Anti-Influenza Agent ZX-7101A Tablets in Healthy Chinese Participants: A First-in-Human Phase I Clinical StudyINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2025, 65 (01)Wu, JunzhenWei, QiongJin, YiCao, GuoyingYu, JichengWu, XiaojieYang, XinyiLi, YilinLiu, MeiQin, XiaoliAi, JingwenWang, YinZhang, WenhongZhang, Jing
- [37] A Five-in-One First-in-Human Study To Assess Safety, Tolerability, and Pharmacokinetics of RO7049389, an Inhibitor of Hepatitis B Virus Capsid Assembly, after Single and Multiple Ascending Doses in Healthy ParticipantsANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)Feng, ShengGane, EdwardSchwabe, ChristianZhu, MingfenTriyatni, MiriamZhou, JulianBo, QingyanJin, Yuyan
- [38] First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese SubjectsFRONTIERS IN PHARMACOLOGY, 2022, 13Zhang, HongGao, LeiLou, JinfengWu, MinChen, HongYang, LizhiLiu, JingruiZhu, XiaoxueLi, XiaojiaoLi, CuiyunWang, MengLiu, ChengjiaoGuo, WeiboWang, YuanGao, ZhongqiangHan, LeiWang, DaidiJin, WeiliDing, Yanhua
- [39] SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia AHAEMOPHILIA, 2020, 26 (01) : 47 - 55Tiede, AndreasAllen, GeoffreyBauer, AlexanderChowdary, PratimaCollins, PeterGoldstein, BrahmJiang, Hongyu JeanneKock, KathleenTakacs, IstvanTimofeeva, MargaritaWolfsegger, MartinSrivastava, Shouryadeep
- [40] A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjectsINTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)Yang, HaijingWang, PeipeiLi, XinWei, QiongYu, JichengWu, XiaojieHuang, YingLi, RuowanDu, WeijuanZeng, ShaoqingWu, HailanWang, ShuhaiZhang, Jing